Starpharma's Nasal Spray Reduces SARS-CoV-2 by Over 99.9% in Animal Studies

A new antiviral nasal spray by Melbourne biotechnology firm Starpharma reportedly shows effectiveness against SARS-CoV-2 infection following a successful animal trial.